Drooling in Parkinson ’s Disease: Evidence of a Role for Divided Attention

This study assessed whether frequency of saliva swallows reduced, and drooling severity and frequency increased, when people with PD engaged in a cognitively distracting task. 18 patients with idiopathic PD reporting daytime dro oling on the Unified Parkinson’s Disease Rating Scale (UPDRS) were recruited. They completed the Radboud Oral Motor Inventory for PD saliva questionnaire and the Montreal Cognitive Assessment. UPDRS drooling score, disease stage, duration, gender, and age were recorded. Swallow frequency and drool ing severity and frequency were measured at rest and during a distracting computer-based language task. There was no significant difference between drooling severity at rest and during distraction (Wilcoxon signed rank testz = − 1.724,p = 0.085). There was a significant difference between at rest and distraction conditions for both drooling frequency (Wilcoxon signed rank testz = − 2.041,p = 0.041) and swallow frequency (Wilcoxon signed rank testz = − 3.054,p = 0.002). Participants swallowed less frequently and drooled more often during the distraction task. The frequency of saliva swallows and drooling are affected by divided attention in a dual-task paradigm. Further studies are needed to explore the exact role of attention in saliva management an d the clinical applications in assessment and treatment.
Source: Dysphagia - Category: Speech-Language Pathology Source Type: research

Related Links:

Johnson &Johnson (NYSE:JNJ) opened its latest life science incubator in New York City, the healthcare giant said today. The 30,000-square-foot JLabs @ NYC is a collaboration between Johnson &Johnson Innovation, New York State and the New York Genome Center. Sited at the genome center in SoHo, the incubator is home to 26 startups and has room for four more, New Brunswick, N.J.-based J&J said. “Johnson &Johnson has deep entrepreneurial roots in New York and we are pleased to see our unique JLabs model applied in this rich ecosystem to foster the creation of new healthcare innovations that have the pote...
Source: Mass Device - Category: Medical Devices Authors: Tags: Funding Roundup Research & Development johnsonandjohnson Source Type: news
Condition:   Parkinson Disease Interventions:   Behavioral: Experimental training;   Behavioral: Control training Sponsors:   University of Sao Paulo General Hospital;   University of Brasilia;   Universidade Federal do Rio Grande do Norte Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Ten-year follow-up of patients with Parkinson's disease who underwent subthalamic deep-brain stimulation (DBS) shows they had lower risk for psychosis and falls than those not receiving DBS.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Almost half of patients with Parkinson's disease who take dopamine agonists develop impulse control disorders at 5 years, a large longitudinal study shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
THURSDAY, June 21, 2018 -- For patients with Parkinson's disease (PD), dopamine agonist (DA) use is associated with incidence of impulse control disorders (ICDs) in a dose-effect relationship, according to a study published online June 20 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
In conclusion, the immune function of T cells in patients suffering from PD is low, and the immune function of T cells in patients with severe disease is lower. Therefore, it is of certain significance to further study the pathophysiological mechanism of PD. PMID: 29921400 [PubMed - in process]
Source: Journal of Biological Regulators and Homeostatic Agents - Category: Biomedical Science Tags: J Biol Regul Homeost Agents Source Type: research
A new study finds that, with time, half of those who take dopamine agonists develop compulsive shopping, eating, gambling, or sexual behaviors.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Parkinson's Disease Source Type: news
A new study finds that, with time, half of those who take dopamine agonists develop compulsive shopping, eating, gambling, or sexual behaviors.
Source: Parkinson's Disease News From Medical News Today - Category: Neurology Tags: Parkinson's Disease Source Type: news
Authors: Woitalla D, Dunac A, Safavi A, Ceravolo MG, Gomez Esteban JC, Pavese N, Asgharnejad M, Joeres L, Schuller JC, Chaudhuri KR Abstract BACKGROUND: PD0013 was a 6-month noninterventional study in clinical practice comparing effectiveness/tolerability of rotigotine+levodopa in younger (
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research
Acta Neurologica Scandinavica, EarlyView.
Source: Acta Neurologica Scandinavica - Category: Neurology Authors: Source Type: research
More News: Computers | Parkinson's Disease | Respiratory Medicine | Speech-Language Pathology | Study